{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "K",
          "alt": "R",
          "position": "48"
        },
        "variant_string_id": "PARK2 K48R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is an E3-ubiquitin ligase involved in neurodegenerative disorder Parkinsonâ€™s disease. Pathogenic Parkin mutations disrupt autoinhibition, resulting in a constitutively active molecule.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, focusing on the disruption of autoinhibition in Parkin leading to constitutive activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper describes the use of autoubiquitination assays to assess the activity of Parkin variants, which is a standard method for evaluating the function of E3 ubiquitin ligases.",
          "judgment": "Yes",
          "reasoning": "Autoubiquitination assays are a relevant and widely accepted method for assessing the functionality of E3 ubiquitin ligases, including Parkin.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls and replicates for the autoubiquitination assays, and the assays were conducted under standard conditions, making them valid for evaluating the specific Parkin variants."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The K48R variant in Parkin was found to disrupt the autoinhibition of Parkin, leading to constitutive activity, which is a pathogenic mechanism in Parkinson's disease. The functional assays used were appropriate and valid for assessing the impact of this variant on Parkin function, resulting in a very strong pathogenic evidence strength rating."
    }
  ]
}